Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fenske

Showing results (1041-1050 of 1,142) with videos related to

Pageof 115
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2017
Central noradrenaline transporter availability in highly obese, non-depressed individualsSwen Hesse, Georg-Alexander Becker, Michael Rullmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2015
Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography studySwen Hesse, Michael Rullmann, Julia Luthardt, et al.
Leukemia & Lymphoma|July 9, 2025
Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201Charalambos Andreadis, Olivia Bobek, Eric D Hsi, et al.
The Lancet. Haematology|August 28, 2020
Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trialCatherine S Diefenbach, Fangxin Hong, Richard F Ambinder, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2020
Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival OutcomesSaurabh Chhabra, Ravi K Narra, Ruizhe Wu, et al.
AIDS (London, England)|July 20, 2002
Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)Hans-Jürgen Stellbrink, Jan van Lunzen, Michael Westby, et al.
The Journal of Infectious Diseases|September 28, 2018
Cutaneous Viral Infections Across 2 Anatomic Sites Among a Cohort of Patients Undergoing Skin Cancer ScreeningDana E Rollison, Michael J Schell, Neil A Fenske, et al.
The Journal of Infectious Diseases|October 13, 2009
Hospital-based surveillance of rotavirus and other viral agents of diarrhea in children and adults in Russia, 2005-2007A T Podkolzin, E B Fenske, N Yu Abramycheva, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 6, 2017
Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research AnalysisMehdi Hamadani, Abraham S Kanate, Alyssa DiGilio, et al.
Journal of Pain and Symptom Management|January 2, 2025
Cigarette Smoking and Symptom Burden: Baseline Results From Nine ECOG-ACRIN Cancer Clinical TrialsSarah N Price, Ju-Whei Lee, Ilana F Gareen, et al.
Pageof 115

Showing results (1041-1050 of 1,142) with videos related to

Sort By:
Pageof 115
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2017
Central noradrenaline transporter availability in highly obese, non-depressed individualsSwen Hesse, Georg-Alexander Becker, Michael Rullmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2015
Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography studySwen Hesse, Michael Rullmann, Julia Luthardt, et al.
Leukemia & Lymphoma|July 9, 2025
Ibrutinib added to standard conditioning and as maintenance therapy following autologous hematopoietic stem cell transplantation for relapsed or refractory activated-B-cell type Diffuse Large B-cell lymphoma: primary analysis of the US intergroup double-blind randomized phase III study Alliance A051301/BMT-CTN 1201Charalambos Andreadis, Olivia Bobek, Eric D Hsi, et al.
The Lancet. Haematology|August 28, 2020
Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trialCatherine S Diefenbach, Fangxin Hong, Richard F Ambinder, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 27, 2020
Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival OutcomesSaurabh Chhabra, Ravi K Narra, Ruizhe Wu, et al.
AIDS (London, England)|July 20, 2002
Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)Hans-Jürgen Stellbrink, Jan van Lunzen, Michael Westby, et al.
The Journal of Infectious Diseases|September 28, 2018
Cutaneous Viral Infections Across 2 Anatomic Sites Among a Cohort of Patients Undergoing Skin Cancer ScreeningDana E Rollison, Michael J Schell, Neil A Fenske, et al.
The Journal of Infectious Diseases|October 13, 2009
Hospital-based surveillance of rotavirus and other viral agents of diarrhea in children and adults in Russia, 2005-2007A T Podkolzin, E B Fenske, N Yu Abramycheva, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 6, 2017
Allogeneic Hematopoietic Cell Transplantation for Aggressive NK Cell Leukemia. A Center for International Blood and Marrow Transplant Research AnalysisMehdi Hamadani, Abraham S Kanate, Alyssa DiGilio, et al.
Journal of Pain and Symptom Management|January 2, 2025
Cigarette Smoking and Symptom Burden: Baseline Results From Nine ECOG-ACRIN Cancer Clinical TrialsSarah N Price, Ju-Whei Lee, Ilana F Gareen, et al.
Pageof 115